A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants
Clinical trial NCT01656018 · COMPLETED
Trial details
- NCT number
- NCT01656018
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2016-01-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.